The nucleus accumbens (NAcc) is a small but powerful structure in the brain’s basal forebrain. It acts as a hub for processing reward and motivation.
Its role, though, is more about wanting a reward than simply feeling pleasure from it (Berridge & Robinson, 1998).
Think of it as the brain’s motivational switchboard. It helps us decide what feels good, what’s worth pursuing, and what behaviors to repeat.
Where Is It Located?
The nucleus accumbens is located deep in the brain, near the front, in a region called the ventral striatum. This is the part of the striatum linked to motivation and reward, rather than movement.
Each hemisphere of the brain has its own nucleus accumbens. It sits where the caudate and putamen meet, close to the prefrontal cortex and the brain’s dopamine pathways.
This structure has two major parts:
- Core: Connects to areas involved in movement and action.
- Shell: Connects to emotional and limbic regions, processing feelings and motivation.
Together, these regions help transform motivation into action.
Functions
The nucleus accumbens plays a key role in:
- Reward and motivation: It responds most strongly to a reward’s anticipation, not its arrival, tracking how much we want something before we get it (Knutson et al., 2001).
- Reinforcement learning: It helps us learn which behaviors lead to rewards and encourages us to repeat them.
- Motivation and decision-making: It influences how strongly we pursue goals or avoid risks.
Much of this activity depends on dopamine, a neurotransmitter associated with motivation, novelty, and learning.
When dopamine is released from the ventral tegmental area (VTA), it floods the nucleus accumbens, encouraging us to seek more of whatever triggered the response.
Beyond Rewards: A Complex Role
While the nucleus accumbens is best known for processing rewards, it’s also involved in other functions:
- Responding to both positive and negative stimuli
- Impulsivity and risk-taking
- Locomotion and movement planning
- Sexual motivation and social bonding
- Linking memories and emotions to experiences
Its connections with the hippocampus and amygdala allow it to tag emotional and contextual meaning to rewards or threats.
Wanting vs. Liking: Why It Isn’t Simply a “Pleasure Centre”
Popular writing often calls the nucleus accumbens the brain’s “pleasure centre,” but this is misleading. Research separates wanting a reward (the motivation to pursue it) from liking it (the pleasure it actually delivers) (Berridge & Robinson, 1998).
Dopamine in the nucleus accumbens drives wanting, not liking. Rats with their accumbens dopamine almost completely depleted still show normal pleasure reactions to a sweet taste, yet they stop working to obtain food (Berridge & Robinson, 1998). The pleasure survives; only the motivation to pursue it disappears.
Actual pleasure comes from a much smaller, separate system. Tiny “hedonic hotspots” in the accumbens shell use opioid and cannabinoid chemicals to amplify liking reactions (Berridge & Kringelbach, 2015).
This is why addiction can make people crave a drug more and more while enjoying it less and less. The “wanting” system becomes hypersensitive even as liking fades.
How Does It Affect Mental Health?
Because the nucleus accumbens is central to reward and motivation, disruptions in its function are linked to several psychological and neurological conditions:
Addiction
Drugs like cocaine, heroin, and even nicotine or alcohol trigger strong dopamine surges in the NAcc.
Over time, this rewires the brain’s reward system, making people crave substances and lose interest in everyday rewards. This helps explain why addiction is so hard to break.
This happens because repeated drug use makes the “wanting” system hypersensitive, even as the drug’s actual pleasure fades. Addicted people often want a drug more and more. Yet they get less enjoyment from it over time (Robinson & Berridge, 1993).
This is why craving can persist long after someone stops enjoying the drug. Cues linked to past use, such as people, places, or paraphernalia, can trigger intense cravings even years into recovery.
Depression and Mood Disorders
People with depression often show reduced NAcc activity (Heller et al., 2009). They may find it harder to enjoy life, feel motivated, or pursue rewarding activities.
Studies using deep brain stimulation targeting the NAcc have shown promising results in treatment-resistant depression (Bewernick et al., 2010).
Anxiety and OCD
The nucleus accumbens connects closely with the amygdala, a region involved in fear and anxiety.
Dysregulation here may contribute to anxiety disorders and obsessive-compulsive disorder (OCD). Deep brain stimulation of the NAcc has been used to reduce OCD symptoms (Denys et al., 2010).
Parkinson’s and Alzheimer’s Disease
Apathy in Parkinson’s disease and motivational issues in Alzheimer’s have been linked to atrophy or dopamine disruption in the NAcc (Carriere et al., 2014).
These findings point to its broader role in goal-directed behavior and cognitive processing.
Critical Evaluation
Is It Really a “Reward Centre”?
The nucleus accumbens is often called the brain’s “reward centre,” and there is some truth in this: it is where nearly all rewards and drugs raise dopamine. But taken literally, the label misses two things.
- Not a Single Centre: The accumbens works only within a wider circuit: the VTA, prefrontal cortex, amygdala and hippocampus all contribute, so reward is a whole-network property, not one structure’s alone.
- Not Reward-Only: The same tissue also responds to stress, fear, and other aversive signals, and helps compute how much effort a behaviour is worth, not just how rewarding it is.
Even the label’s kernel of truth is about motivation, not pleasure: the accumbens is best described as the reward circuit’s motivational gateway, not a pleasure organ.
Methodological Limitations
Much of the strongest evidence for how the accumbens works comes with real caveats.
- Mostly Animal Evidence: The cleanest findings come from rats and mice, such as dopamine-depletion studies. Applying them to human wanting and liking is a reasonable inference, not a proven fact.
- Correlational Human Data: Human brain-imaging studies show the accumbens is active during reward and anticipation, but activity alone does not prove the region causes the behaviour (Knutson et al., 2001).
- Small Clinical Trials: Deep brain stimulation has helped some patients with treatment-resistant depression and OCD. But the depression trials are small, and results across larger studies have been inconsistent (Bewernick et al., 2010; Denys et al., 2010).
None of this undermines the core picture, but it means confidence should scale with the evidence: strong for the basic reward-and-motivation mechanism, more cautious for any single clinical claim.
Contemporary Research
Research since 2015 has moved from asking whether the accumbens supports reward to asking how its specific circuits produce different parts of motivated behaviour.
- Aim: To determine how two subdivisions of the accumbens shell control the dopamine neurons of the VTA that feed back onto them.
- Method: In mice, researchers combined tracing, electrophysiology, and optogenetics to switch specific accumbens-to-VTA projections on and off and measure the effect on motivated behaviour.
- Results: The two shell subregions had opposite effects. The medial shell directly inhibited VTA dopamine neurons, while the lateral shell disinhibited them by acting on nearby GABA interneurons.
- Conclusion: The accumbens does not control its own dopamine supply uniformly. Nearby subregions of the shell can inhibit or release it through separate circuits (Yang et al., 2018).
This fits a wider pattern in recent work. The accumbens is not one uniform “reward” module, but a set of distinct circuits that can push behaviour in different directions.
FAQs
What happens if the nucleus accumbens is damaged?
Damage or dysfunction in the nucleus accumbens can lead to problems with motivation, reward processing, and mood regulation.
This may contribute to conditions like depression, apathy, addiction, or even chronic pain sensitivity.
Is the nucleus accumbens involved in learning or memory?
Yes. It helps form associations between experiences and their emotional or motivational value—essential for learning from rewards or punishments.
Is the nucleus accumbens part of the limbic system or basal ganglia?
It’s part of both. Anatomically, it’s located in the basal ganglia, but functionally it connects closely with the limbic system—linking emotion with action.
Key Takeaways
- Location: The NAcc sits in the ventral striatum, deep in the basal forebrain, with one copy in each hemisphere.
- Core vs Shell: The core drives goal-directed action, while the shell handles emotional and hedonic reactions.
- Wanting vs Liking: Its dopamine signal drives the motivation to pursue a reward, not the pleasure of receiving it.
- Addiction: Drugs hijack this “wanting” system, so craving can grow even as the pleasure from a drug fades.
- Depression Link: Reduced or unsustained accumbens activity is linked to low motivation and anhedonia, the loss of pleasure in things once enjoyed.
- Beyond Reward: Newer circuit research shows the same structure also processes fear, stress, and other non-reward signals.
References
Berns, G. S., McClure, S. M., Pagnoni, G., & Montague, P. R. (2001). Predictability modulates human brain response to reward. Journal of neuroscience, 21(8), 2793-2798.
Berridge, K. C., & Kringelbach, M. L. (2015). Pleasure systems in the brain. Neuron, 86(3), 646–664. https://doi.org/10.1016/j.neuron.2015.02.018
Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28(3), 309–369. https://doi.org/10.1016/S0165-0173(98)00019-8
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., Brockmann, H., Lenartz, D., Sturm, V. & Schlaepfer, T. E. (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological psychiatry, 67(2), 110-116.
Carriere, N., Besson, P., Dujardin, K., Duhamel, A., Defebvre, L., Delmaire, C., & Devos, D. (2014). Apathy in Parkinson’s disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis. Movement disorders, 29(7), 897-903.
Denys, D., Mantione, M., Figee, M., Van Den Munckhof, P., Koerselman, F., Westenberg, H., Bosch, A. & Schuurman, R. (2010). Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Archives of general psychiatry, 67(10), 1061-1068.
Du, K., Lu, W., Sun, Y., Feng, J., & Wang, J. H. (2019). mRNA and miRNA profiles in the nucleus accumbens are related to fear memory and anxiety induced by physical or psychological stress. Journal of psychiatric research, 118, 44-65.
Heller, A. S., Johnstone, T., Shackman, A. J., Light, S. N., Peterson, M. J., Kolden, G. G., Kalin, N. H. & Davidson, R. J. (2009). Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activation. Proceedings of the National Academy of Sciences, 106(52), 22445-22450.
Knutson, B., Adams, C. M., Fong, G. W., & Hommer, D. (2001). Anticipation of increasing monetary reward selectively recruits nucleus accumbens. Journal of Neuroscience, 21(16), RC159-RC159.
Makary, M. M., Polosecki, P., Cecchi, G. A., DeAraujo, I. E., Barron, D. S., Constable, T. R., Whang, P. G., Thomas, D. A., Mowafi, H., Small, D. M. & Geha, P. (2020). Loss of nucleus accumbens low-frequency fluctuations is a signature of chronic pain. Proceedings of the National Academy of Sciences, 117(18), 10015-10023.
Mavridis, I. (2015). The role of the nucleus accumbens in psychiatric disorders. Psychiatrike= Psychiatriki, 25(4), 282-294.
Mogenson, G. J., Jones, D. L., & Yim, C. Y. (1980). From motivation to action: functional interface between the limbic system and the motor system. Progress in neurobiology, 14(2-3), 69-97.
Nobili, A., Latagliata, E. C., Viscomi, M. T., Cavallucci, V., Cutuli, D., Giacovazzo, G., Krashia, P., Romana Rizzo, F., Marino, R., Federici, M., De Bartolo, P., Aversa, D., Concetta Dell’Acqua, M., Cordella, A., Sancandi, M., Keller, F., Petrosini, L., Puglisi-Allegra, S., Biagio Mercuri, N., Coccurello, R., Berretta, N. & D’Amelio, M. (2017). Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease. Nature communications, 8(1), 1-14.
Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18(3), 247–291. https://doi.org/10.1016/0165-0173(93)90013-P
Salgado, S., & Kaplitt, M. G. (2015). The nucleus accumbens: a comprehensive review. Stereotactic and functional neurosurgery, 93(2), 75-93.
Volman, S. F., Lammel, S., Margolis, E. B., Kim, Y., Richard, J. M., Roitman, M. F., & Lobo, M. K. (2013). New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system. Journal of Neuroscience, 33(45), 17569-17576. https://doi.org/10.1523/JNEUROSCI.3250-13.2013
Wise, R. A. (1982). Neuroleptics and operant behavior: the anhedonia hypothesis. Behavioral and brain sciences, 5(1), 39-53.
Yang, H., de Jong, J. W., Tak, Y., Peck, J., Bateup, H. S., & Lammel, S. (2018). Nucleus accumbens subnuclei regulate motivated behavior via direct inhibition and disinhibition of VTA dopamine subpopulations. Neuron, 97(2), 434–449. https://doi.org/10.1016/j.neuron.2017.12.022
Zabek, M., Sobstyl, M., Koziara, H., & Dzierzecki, S. (2008). Deep brain stimulation of the right nucleus accumbens in a patient with Tourette syndrome. Case report. Neurologia i neurochirurgia polska, 42(6), 554-559.
